Showing papers for search query "FDA"+"Continuous"

     Search term "FDA"+"Continuous"
     Title FDA perspective on continuous manufacturing
     Author ['S Chatterjee']
     Venue IFPAC Annual Meeting, Baltimore, MD
     Year 2012
     Abstract Lot-a batch, or a specific identified portion of a batch, having uniform character and quality within specified limits; or, in the case of a drug product produced by continuous process, it is a specific identified amount produced in a unit of time or quantity in a manner that assures its
     Url http://gmpua.com/Process/ContinuousManufacturing/ContinuousManufacturing.pdf


     Search term "FDA"+"Continuous"
     Title The FDA panel advises approval of the first continuous glucose sensor
     Author ['BH Ginsberg']
     Venue Diabetes technology & therapeutics
     Year 1999
     Abstract ON FEBRUARY 26, 1999, an FDA advisory panel recommended the approval of the Minimed Continuous Glucose Monitoring System (CGMS) after certain additional studies are performed. This is a landmark recommendation with important ramifications for patients with
     Url https://www.liebertpub.com/doi/pdfplus/10.1089/152091599317431


     Search term "FDA"+"Continuous"
     Title FDA approval of nonadjunctive use of continuous glucose monitors for insulin dosing: a potentially risky decision
     Author ['AR Shapiro']
     Venue Jama
     Year 2017
     Abstract On December 20, 2016, the US Food and Drug Administration (FDA) approved labeling for use of the Dexcom G5 Mobile continuous glucose monitor (CGM) for making diabetes treatment decisions without a need for confirmation of the device's readings with fingerstick
     Url https://jamanetwork.com/journals/jama/article-abstract/2654258


     Search term "FDA"+"Continuous"
     Title Current FDA perspective for continuous manufacturing
     Author ['SL Lee']
     Venue 2nd International Symposium on Continuous …
     Year 2016
     Abstract CM process for an FDA-approved HIV drug (tablet) (April 2016)2 • Over 15 ETT-Industry meetings since the launch of ETT program in early 2014 providing feedback on the development of CM processes – Drug substance – Drug product – Small-molecule and biotechnology products
     Url http://iscmp.mit.edu/sites/default/files/documents/ISCMP%202016%20-%20FDA%20MIT-CMAC%20for%20CM%202016%20Ver6.pdf


     Search term "FDA"+"Continuous"
     Title FDA Focuses on Innovation, Quality, and Continuous Improvement—Inside and Out
     Author ['FDA As']
     Venue Pharmaceutical Technology
     Year 2004
     Abstract research by organizations such as the National Institutes of Health (NIH) also may be required. Woodcock stresses that a multidisciplinary approach is crucial.“The fact that the kind of work needed is so multidisciplinary is probably part of why it has been neglected,”
     Url https://pdfs.semanticscholar.org/3f97/4fcd092a779b8a2e1539566b16e157a47275.pdf


     Search term "FDA"+"Continuous"
     Title FDA/OBP laboratory research to support continuous bioprocessing
     Author ['S Lute', 'C Agarabi', 'S Johnson', 'B Chavez', 'K Brorson']
     Venue NA
     Year 2017
     Abstract Recently, there has been a movement in commercial biotechnology drug production to develop fully a continuous manufacturing scheme capable of consistent production of high quality therapeutics. The FDA is increasingly reviewing applications implementing elements
     Url https://dc.engconfintl.org/biomanufact_iii/10/


     Search term "FDA"+"Continuous"
     Title Janssen working on other continuous processes post US FDA OK for Prezista
     Author ['G MacDonald']
     Venue inpharmatechnologist. com
     Year 2016
     Abstract Page 1. 22/04/2016, 17:12 Janssen working on other continuous processes post US FDA OK for Prezista Page 1 of 1 http://www.in-pharmatechnologist.com/content/view/print/1244480  By Gareth MacDonald+, 13-Apr-2016 Related topics: Processing equipment, Regulations
     Url http://swedish.troudigital.com/wp-content/uploads/2016/01/Janssen-working-on-other-continuous-processes-post-US-FDA-OK-for-Prezista.pdf


     Search term "FDA"+"Continuous"
     Title The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?
     Author ['C Meyer‐Massetti', 'CM Cheng']
     Venue Journal of hospital …
     Year 2010
     Abstract Considering the widespread use of IV haloperidol in the management of acute delirium, the specific FDA recommendation of continuous electrocardiogram (ECG) monitoring in this setting has been associated with some controversy
     Url https://onlinelibrary.wiley.com/doi/abs/10.1002/jhm.691


     Search term "FDA"+"Continuous"
     Title Present and future for continuous manufacturing: FDA perspective
     Author ['S Lee']
     Venue Proceedings of the 3rd FDA/PQRI Conference on …
     Year 2017
     Abstract Met the PDUFA timeline (4 mouths) • Over 15 ETT-Industry meetings since the launch of ETT program in early 2014 providing feedback on the development of CM processes – Drug substance – Drug product – Small-molecule and biotechnology products – Control strategy utilizing models
     Url http://pqri.org/wp-content/uploads/2017/02/1-Lee-PQRI-for-CM-2017.pdf


     Search term "FDA"+"Continuous"
     Title Modernizing pharmaceutical manufacturing: from batch to continuous production
     Author ['SL Lee', "TF O'Connor", 'X Yang', 'CN Cruz']
     Venue Journal of …
     Year 2015
     Abstract The Food and Drug Administration (FDA) regulates pharmaceutical drug products to ensure a continuous supply of high-quality drugs in the USA  The FDA supports the implementation of continuous manufacturing using science- and risk-based approaches. Keywords
     Url https://link.springer.com/article/10.1007/s12247-015-9215-8

